Laser-assisted topical drug delivery by using a low-fluence fractional laser: Imiquimod and macromolecules

Journal of Controlled Release

Volumn 153, Issue 3, 2011, Pages 240-248

  Lee, Woan Ruoh ^a,b   Shen, Shing Chuan ^a   Al Suwayeh, Saleh A ^c   Yang, Hung Hsu ^a   Yuan, Cheng Yin ^d   Fang, Jia You ^c,d,e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Fractional laser; Imiquimod; Macromolecules; Peptides; Skin permeation

Indexed keywords

BARRIER MODEL; CONFOCAL LASER SCANNING MICROSCOPY; DIFFUSION CELLS; DRUG TRANSPORT; ENHANCING EFFECT; FLUENCES; FLUORESCEIN ISOTHIOCYANATE; FRACTIONAL LASER; GREEN FLUORESCENCE; IMIQUIMOD; IN-VITRO; IN-VIVO; LASER FLUENCES; LASER TREATMENT; LASER-ASSISTED; NUDE MICE; PERMEANTS; PORCINE SKIN; SEQUENCE-DEPENDENT; SKIN DELIVERY; SKIN PERMEATION; ULTRA-VIOLET;

CONFOCAL MICROSCOPY; DRUG DELIVERY; ERBIUM; FINITE DIFFERENCE METHOD; MACROMOLECULES; MAMMALS; PEPTIDES;

DRUG DOSAGE;

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; IMIQUIMOD; POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CREAM; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; ERBIUM YAG LASER; EXPOSURE; FEMALE; FLUORESCENCE; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; MACROMOLECULE; MOLECULAR SIZE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SKIN PERMEABILITY; SWINE; ULTRAVIOLET IRRADIATION;

ADMINISTRATION, CUTANEOUS; AMINOQUINOLINES; ANIMALS; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEXTRANS; DRUG DELIVERY SYSTEMS; FEMALE; LASERS, SOLID-STATE; MACROMOLECULAR SUBSTANCES; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; PEPTIDES; SKIN; SKIN ABSORPTION; SWINE; ULTRAVIOLET RAYS;

EID: 79960930858     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.03.015     Document Type: Article

References (47)

1. G. Hadley, S. Derry, R.A. Moore, Imiquimod for actinic keratosis: systematic review and meta-analysis, J. Invest. Dermatol. 126 (2006) 1251-1255. (Pubitemid 43997904)
2. H. Schöfer, Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies, Br. J. Dermatol. 157 (Suppl. 2) (2007) 52-55. (Pubitemid 350179631)
3. N. Swanson, W. Abramovits, B. Berman, J. Kulp, D.S. Rigel, S. Levy, Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles, J. Am. Acad. Dermatol. 62 (2010) 582-590.
4. S. Metcalf, N. Crowson, M. Naylor, R. Haque, R. Cornelison, Imiquimod as an antiaging agent, J. Am. Acad. Dermatol. 56 (2007) 422-425. (Pubitemid 46273849)
5. M. Wuest, R. Dummer, M. Urosevic, Induction of the members of Notch pathway in superficial basal cell carcinomas treated with imiquimod, Arch. Dermatol. Res. 299 (2007) 493-498. (Pubitemid 350160057)
6. J. Anwar, D.A. Wrone, A. Kimyai-Asadi, M. Alam, The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes, Clin. Dermatol. 22 (2004) 189-196. (Pubitemid 38950745)
7. L.I. Harrison, S.L. Skinner, T.C.Marbury,M.L. Owens, S. Kurup, S.McKane, R.J. Greene, Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms, Arch.Dermatol. Res. 296 (2004) 6-11. (Pubitemid 38828417)
8. E. Stockfleth, W. Sterry,M. Carey-Yard, J. Bichel,Multicentre, open-label study using imiquimod 5% creamin one or two 4-week courses of treatment formultiple actinic keratoses on the head, Br. J. Dermatol. 157 (Suppl. 2) (2007) 41-46. (Pubitemid 350179629)
9. S. Salasche, S. Shumack, A review of imiquimod 5% cream for the treatment of various dermatological conditions, Clin. Exp. Dermatol. 28 (2003) 1-3.
10. D.B. Yarosh, M.T. Canning, D. Teicher, D.A. Brown, After sun reversal of DNA damage: enhancing skin repair, Mutat. Res. 571 (2005) 57-64. (Pubitemid 40313432)
11. B. Berman, S. Amini, W. Valins, S. Block, Pharmacotherapy of actinic keratosis, Exp. Opin. Pharmacother. 10 (2009) 3015-3031.
12. Y. Chen, Y. Shen, X. Guo, C. Zhang, W. Yang, M. Ma, S. Liu, M. Zhang, L.P. Wen, Transdermal protein delivery by a coadministered peptide identified via phage display, Nat. Biotechnol. 24 (2006) 455-460.
13. S.O. Francis, M.J. Mahlberg, K.R. Johnson, M.E. Ming, R.P. Dellavalle, Melanoma chemoprevention, J. Am. Acad. Dermatol. 55 (2006) 849-861. (Pubitemid 44556826)
14. J.A. Mikszta, J.B. Alarcon, J.M. Brittingham, D.E. Sutter, R.J. Pettis, N.G. Harrey, Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery, Nat. Med. 8 (2002) 415-419. (Pubitemid 34407039)
15. M. Ogura, S. Sato, K. Nakanishi, M. Uenoyama, T. Kiyozumi, D. Saitoh, T. Ikeda, H. Ashida, M. Obara, In vivo targeted gene transfer in skin by the use of laser-induced stress waves, Lasers Surg. Med. 34 (2004) 242-248. (Pubitemid 38420425)
16. C. Gómez, Á. Costela, I. Carcía-Moreno, F. Llanes, J.M. Teijón, D. Blanco, Laser treatments on skin enhancing and controlling transdermal delivery of 5-fluorouracil, Lasers Surg. Med. 40 (2008) 6-12. (Pubitemid 351214118)
17. W.R. Lee, S.C. Shen, R.Z. Zhuo, K.C. Wang, J.Y. Fang, Enhancement of topical small interfering RNA delivery and expression by low-fluence erbium:YAG laser pretreatment of skin, Hum. Gene Ther. 20 (2009) 580-588.
18. S.C. Shen, W.R. Lee, Y.P. Fang, C.H. Hu, J.Y. Fang, In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser, J. Pharm. Sci. 95 (2006) 929-938.
19. I.B. Allemann, J. Kaufman, Fractional photothermolysis-an update, Lasers Med. Sci. 25 (2010) 137-144.
20. D.J. Goldberg, A.L. Berlin, R. Phelps, Histologic and ultrastructural analysis of melasma after fractional resurfacing, Lasers Surg. Med. 40 (2008) 134-138. (Pubitemid 351354769)
21. W.R. Lee, S.C. Shen, M.H. Pai, H.H. Yang, C.Y. Yuan, J.Y. Fang, Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid withminimal skin disruption: a comparison with conventional erbium:YAG laser, J. Control. Release 145 (2010) 124-133.
22. R.F. Donnelly, D.I.J. Morrow, P.A. McCarron, A.D. Woolfson, A. Morrissey, P. Juzenas, A. Juzeniene, V. Iani, H.O. McCarthy, J. Moan, Microneedle-mediated intradermal of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy, J. Control. Release 129 (2008) 154-162.
23. W.R. Lee, T.L. Pan, P.W. Wang, R.Z. Zhuo, C.M. Huang, J.Y. Fang, Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination, J. Control. Release 128 (2008) 200-208.
24. D. Manstein, G.S. Herron, R.K. Sink, H. Tanner, R.R. Anderson, Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury, Lasers Surg. Med. 34 (2004) 426-438. (Pubitemid 38890753)
25. M. Demerjian, M.Q. Mao, E.H. Choi, B.E. Brown, D. Crumrine, S. Chang, T. Mauro, P.M. Elias, K.R. Feingold, Topical treatment with thiazolidinediones, activators of peroxisome proliferators-activated receptor-γ, normalizes epidermal homeostasis in a murine hyperproliferative disease model, Exp. Dermatol. 15 (2006) 154-160.
26. J.O. Moore, S.R. Palep, R.N. Saladi, D. Gao, Y. Wang, R.G. Phelps, M.G. Lebwohl, H. Wei, Effects of ultraviolet B exposure on the expression of proliferating cell nuclear antigen in murine skin, Photochem. Photobiol. 80 (2004) 587-595. (Pubitemid 40174490)
27. T.M. Chiu, C.C. Huang, T.J. Lin, J.Y. Fang, N.L. Wu, C.F. Hung, In vitro and in vivo antiphotoaging effects of an isoflavone extract from soybean cake, J. Ethnopharmacol. 126 (2009) 108-113.
28. J.P. Ortonne, From actinic keratosis to squamous cell carcinoma, Br. J. Dermatol. 146 (Suppl. 61) (2002) 20-23.
29. C.J. Smith, Y. Zhang, C.M. Koboldt, J. Muhammad, B.S. Zweifel, A. Shaffer, J.J. Talley, J.L. Masferrer, K. Seibert, P.C. Isakson, Pharmacological analysis of cyclooxygenase-1 in inflammation, Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13313-13318. (Pubitemid 28509568)
30. O.F. Stumpp, V.P. Bedi, D. Wyatt, D. Lac, Z. Rahman, K.F. Chan, In vivo confocal imaging of epidermal cell migration and dermal changes post nonablative fractional resurfacing: study of the wound healing process with corroborated histopathologic evidence, J. Biomed. Opt. 14 (2009) 024018.
31. R.M.P. Manaloto, T. Alster, Erbium:YAG laser resurfacing for refractory melasma, Dermatol. Surg. 25 (1999) 121-123. (Pubitemid 30195951)
32. S. Lee, D.J.McAuliffe, T.J. Flotte,N. Kollias, A.G.Doukas, Photomechanical transdermal delivery: the effect of laser confinement, Lasers Surg. Med. 28 (2001) 344-347. (Pubitemid 32411116)
33. R.J. Caniglia, Erbium:YAG laser resurfacing, Facial Plast. Surg. Clin. North Am. 12 (2004) 373-377.
34. M.P. Schön, M. Schön, Imiquimod: mode of action, Br. J. Dermatol. 157 (Suppl. 2) (2007) 8-13. (Pubitemid 350179622)
35. N. Abla, A. Naik, R.H. Guy, Y.N. Kalia, Effect of charge and molecular weight on transdermal peptide delivery by iontophoresis, Pharm. Res. 22 (2005) 2069-2078. (Pubitemid 41821586)
36. A. Naik, Y.N. Kalia, R.H. Guy, Transdermal drug delivery: overcoming the skin barrier function, Pharm. Sci. Technol. Today 3 (2000) 318-326.
37. P. Svedman, S. Lundin, P. Höglund, C. Hammarlund, C. Malmros, N. Pantzar, Passive drug diffusion via standardized skin mini-erosion; methodological aspects and clinical findings with new device, Pharm. Res. 13 (1996) 1354-1359. (Pubitemid 26344981)
38. F.J. Verbaan, S.M. Bal, D.J. van den Berg, W.H.H. Groenink, H. Verpoorten, R. Lüttge, J.A. Bouwstra, Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin, J. Control. Release 117 (2007) 238-245. (Pubitemid 46161879)
39. C. Lombry, N. Dujardin, V. Préat, Transdermal delivery of macromolecules using skin electroporation, Pharm. Res. 17 (2000) 32-37. (Pubitemid 30121096)
40. M.V. Neidecker, M.L. Davis-Ajami, R. Balkrishnan, S.R. Feldman, Pharmacoeconomic considerations in treating actinic keratosis, Pharmacoeconomics 27 (2009) 451-464.
41. J. Lademann, F. Knorr, H. Richter, U. Blume-Peytavi, A. Vogt, C. Antoniou, W. Sterry, A. Patzelt, Hair follicles-an efficient storage and penetration pathway for topically applied substances, Skin Pharmacol. Physiol. 21 (2008) 150-155.
42. B.D. Bath, E.R. Scott, J.B. Phipps, H.S. White, Scanning electrochemical microscopy of iontophoretic transport in hairless mouse skin. Analysis of the relative contributions of diffusion, migration, and electroosmosis to transport in hair follicles, J. Pharm. Sci. 89 (2000) 1537-1549.
43. J.Y. Fang, W.R. Lee, S.C. Shen, H.Y. Wang, C.L. Fang, C.H. Hu, Transdermal delivery of macromolecules by erbium:YAG laser, J. Control. Release 100 (2004) 75-85.
44. R.F. Donnelly, T.R. Raj Singh, D.Woolfson,Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety, Drug Deliv. 17 (2010) 187-207.
45. A. Davidson, B. Al-Qallaf, D.B. Das, Transdermal drug delivery by coated microneedles: geometry effects on effective skin thickness and drug permeability, Chem. Eng. Res. Des. 86 (2008) 1196-1206.
46. K.A. Khatri, J. Gordon, L. Garamela, Laser skin resurfacing with a novel portable erbium:YAG laser, J. Cosmet. Laser Ther. 8 (2006) 23-25.
47. Y.G. Bachhav, S. Summer, A. Heinrich, T. Bragagna, C. Böhler, Y.N. Kalia, Effect of controlled laser microporation on drug transport kinetics into and across the skin, J. Control. Release 146 (2010) 31-36.